PortfoliosLab logo

Antibe Therapeutics Inc. (ATE.TO)

Equity · Currency in CAD · Last updated Feb 4, 2023

Company Info

ISINCA0370255097
CUSIP037025509
SectorHealthcare
IndustryMedical Devices

ATE.TOShare Price Chart


Loading data...

ATE.TOPerformance

The chart shows the growth of CA$10,000 invested in Antibe Therapeutics Inc. in Sep 2022 and compares it to the S&P 500 index or another benchmark. It would be worth nearly CA$1,073 for a total return of roughly -89.27%. All prices are adjusted for splits and dividends.


-30.00%-20.00%-10.00%0.00%10.00%OctoberNovemberDecember2023February
-10.58%
5.49%
ATE.TO (Antibe Therapeutics Inc.)
Benchmark (^GSPC)

ATE.TOCompare to other instruments

Search for stocks, ETFs, and funds to compare with ATE.TO

Antibe Therapeutics Inc.

ATE.TOReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M18.00%8.17%
YTD25.53%7.73%
6M-3.28%0.79%
1Y-14.49%-11.16%
5Y-20.93%5.35%
10Y-20.77%8.01%

ATE.TOMonthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
202321.28%
202210.00%-7.58%-13.11%-11.32%-0.00%

ATE.TOSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Antibe Therapeutics Inc. Sharpe ratio is -0.27. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


-1.00-0.80-0.60-0.40-0.200.00OctoberNovemberDecember2023February
-0.27
-0.47
ATE.TO (Antibe Therapeutics Inc.)
Benchmark (^GSPC)

ATE.TODividend History


Antibe Therapeutics Inc. doesn't pay dividends

ATE.TODrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%OctoberNovemberDecember2023February
-93.06%
-15.48%
ATE.TO (Antibe Therapeutics Inc.)
Benchmark (^GSPC)

ATE.TOWorst Drawdowns

The table below shows the maximum drawdowns of the Antibe Therapeutics Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Antibe Therapeutics Inc. is 95.29%, recorded on Jan 26, 2015. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-95.29%Mar 24, 2014212Jan 26, 2015
-20%Aug 22, 201380Dec 13, 201332Jan 31, 2014112
-12.94%Mar 10, 20149Mar 20, 20141Mar 21, 201410
-8.7%Feb 18, 20146Feb 25, 20145Mar 4, 201411
-6.9%Jul 29, 201311Aug 13, 20136Aug 21, 201317

ATE.TOVolatility Chart

Current Antibe Therapeutics Inc. volatility is 51.28%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


20.00%40.00%60.00%80.00%100.00%OctoberNovemberDecember2023February
51.28%
16.33%
ATE.TO (Antibe Therapeutics Inc.)
Benchmark (^GSPC)